Pharmacological Profiles of Oligomerized μ-Opioid Receptors
AbstractOpioids are widely prescribed pain relievers with multiple side effects and potential complications. They produce analgesia via G-protein-protein coupled receptors: μ-, δ-, κ-opioid and opioid receptor-like 1 receptors. Bivalent ligands targeted to the oligomerized opioid receptors might be the key to developing analgesics without undesired side effects and obtaining effective treatment for opioid addicts. In this review we will update the biological effects of μ-opioids on homo- or hetero-oligomerized μ-opioid receptor and discuss potential mechanisms through which bivalent ligands exert beneficial effects, including adenylate cyclase regulation and receptor-mediated signaling pathways. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Lee, C.W.-S.; Ho, I.-K. Pharmacological Profiles of Oligomerized μ-Opioid Receptors. Cells 2013, 2, 689-714.
Lee CW-S, Ho I-K. Pharmacological Profiles of Oligomerized μ-Opioid Receptors. Cells. 2013; 2(4):689-714.Chicago/Turabian Style
Lee, Cynthia W.-S.; Ho, Ing-Kang. 2013. "Pharmacological Profiles of Oligomerized μ-Opioid Receptors." Cells 2, no. 4: 689-714.